M&A

J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
BioPharma Dive
Mon, 01/13/25 - 11:19 am
JNJ
Intra-Cellular Therapies
JPMHC 2025
M&A
psychiatric disease
New Acquisition to Strengthen Lantheus’s Position in Alzheimer’s Radiodiagnostic Market
Medical Devices and Diagnostics Industry
Mon, 01/13/25 - 11:08 am
Lantheus
Medtech
M&A
Life Molecular
Alzheimer's disease
Sage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover Bid
Yahoo/Investopedia
Mon, 01/13/25 - 10:54 am
SAGE Therapeutics
Biogen
M&A
Some pharmaceutical mergers lower drug prices: Study
Beckers Hospital Review
Thu, 01/9/25 - 09:15 pm
M&A
drug pricing
Boston Scientific to buy remaining Bolt Medical stake for up to $664M
Medtech Dive
Thu, 01/9/25 - 11:28 am
Boston Scientific
M&A
Medtech
Bolt Medical
Phillips Medisize Boosts Medical Inhaler Portfolio With Vectura Acquisition
Medical Devices and Diagnostics Industry
Wed, 01/8/25 - 11:11 pm
Medtech
Phillips Medisize
M&A
Vectura Group
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Pharma Live
Wed, 01/8/25 - 11:25 am
Roche
M&A
Poseida Therapeutics
blood cancer
Stryker in advanced talks to acquire Inari Medical
Investing.com
Mon, 01/6/25 - 06:47 pm
Medtech
M&A
Stryker
Inari Medical
venous disease
Regeneron Acquisition of Oxular Wipes Out Oxular Workforce
BioSpace
Sun, 01/5/25 - 09:38 pm
Regeneron
Oxular
M&A
layoffs
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Fierce Biotech
Fri, 01/3/25 - 11:17 am
IPOs
M&A
Regeneron acquires UK biotech, adding Oxular's eye disease delivery tech to portfolio
Fierce Biotech
Fri, 01/3/25 - 10:51 am
Regeneron
M&A
Oxular
retinal disease
6 Critical Developments That Could Define the Medical Device Industry in 2025
Medical Devices and Diagnostics Industry
Thu, 01/2/25 - 11:20 am
devices
Medtech
Europe
Medtronic
Abbott Labs
CGMs
JNJ
robotic surgery
Donald Trump
M&A
Medtech M&A Picked Up in 2024, But Belt-Tightening Continues
Medical Devices and Diagnostics Industry
Thu, 12/19/24 - 09:19 pm
Medtech
M&A
Novo completes $16.5bn takeover of Catalent
Pharmaphorum
Thu, 12/19/24 - 10:03 am
Novo Holdings
Catalent
CDMOs
M&A
Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara
Fierce Biotech
Wed, 12/18/24 - 11:13 am
Cara Therapeutics
Tvardi Therapeutics
M&A
fibrosis
Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025
Fierce Pharma
Tue, 12/17/24 - 12:07 pm
Pfizer
Inflation Reduction Act
M&A
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say
MSN/Reuters
Sun, 12/15/24 - 10:52 pm
Novo Holdings
M&A
Catalent
AbbVie to acquire Roche spinout Nimble in immune drug deal
BioPharma Dive
Fri, 12/13/24 - 11:49 am
AbbVie
Nimble Therapeutics
M&A
IL-23
Roche
After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale
Fierce Pharma
Thu, 12/12/24 - 11:47 pm
Bausch + Lomb
M&A
Industry M&A volume declined 8% this year compared to '23
Fierce Biotech
Thu, 12/12/24 - 11:43 am
M&A
PwC

Pages